{"id":12790,"date":"2024-12-12T15:17:36","date_gmt":"2024-12-12T14:17:36","guid":{"rendered":"https:\/\/www.cilcare.com\/?post_type=team&#038;p=12790"},"modified":"2025-05-16T14:53:47","modified_gmt":"2025-05-16T12:53:47","slug":"mathieu-schue-ph-d","status":"publish","type":"team","link":"https:\/\/www.cilcare.com\/jp\/team\/mathieu-schue-ph-d\/","title":{"rendered":"Mathieu SCHUE, Ph.D"},"content":{"rendered":"\n<p>Dr. Schu\u00e9 has over 15 years of experience in life science research. Prior to joining Cilcare, he managed\u00a0R&amp;D\u00a0operations\u00a0in a biotech company specialized in the development of therapeutic proteins to treat cystic fibrosis and chronic pancreatitis. He successfully brought drug candidates\u00a0from preclinical to clinical phases\u00a0and handled the preparation of\u00a0regulatory documents\u00a0to support Phase 2 CTA. Mathieu leads projects to define\u00a0innovative development plan strategies\u00a0of drug candidates specifically for ear disorders as well as identifying\u00a0reference compounds in the various indications of hearing\u00a0for Cilcare\u2019s clients.<\/p>\n","protected":false},"featured_media":9612,"template":"","category-team":[129],"class_list":["post-12790","team","type-team","status-publish","has-post-thumbnail","hentry","category-team-leadership","entry","has-media"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Mathieu SCHUE, Ph.D - Cilcare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cilcare.com\/jp\/team\/mathieu-schue-ph-d\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mathieu SCHUE, Ph.D - Cilcare\" \/>\n<meta property=\"og:description\" content=\"Dr. Schu\u00e9 has over 15 years of experience in life science research. Prior to joining Cilcare, he managed\u00a0R&amp;D\u00a0operations\u00a0in a biotech company specialized in the development of therapeutic proteins to treat cystic fibrosis and chronic pancreatitis. He successfully brought drug candidates\u00a0from preclinical to clinical phases\u00a0and handled the preparation of\u00a0regulatory documents\u00a0to support Phase 2 CTA. Mathieu leads projects to define\u00a0innovative development plan strategies\u00a0of drug candidates specifically for ear disorders as well as identifying\u00a0reference compounds in the various indications of hearing\u00a0for Cilcare\u2019s clients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cilcare.com\/jp\/team\/mathieu-schue-ph-d\/\" \/>\n<meta property=\"og:site_name\" content=\"Cilcare\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-16T12:53:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Mathieu.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"610\" \/>\n\t<meta property=\"og:image:height\" content=\"763\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/\",\"url\":\"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/\",\"name\":\"Mathieu SCHUE, Ph.D - Cilcare\",\"isPartOf\":{\"@id\":\"https:\/\/www.cilcare.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Mathieu.jpg\",\"datePublished\":\"2024-12-12T14:17:36+00:00\",\"dateModified\":\"2025-05-16T12:53:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/#primaryimage\",\"url\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Mathieu.jpg\",\"contentUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Mathieu.jpg\",\"width\":610,\"height\":763},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cilcare.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mathieu SCHUE, Ph.D\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cilcare.com\/#website\",\"url\":\"https:\/\/www.cilcare.com\/\",\"name\":\"Cilcare\",\"description\":\"Making hearing a priority\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cilcare.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mathieu SCHUE, Ph.D - Cilcare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cilcare.com\/jp\/team\/mathieu-schue-ph-d\/","og_locale":"ja_JP","og_type":"article","og_title":"Mathieu SCHUE, Ph.D - Cilcare","og_description":"Dr. Schu\u00e9 has over 15 years of experience in life science research. Prior to joining Cilcare, he managed\u00a0R&amp;D\u00a0operations\u00a0in a biotech company specialized in the development of therapeutic proteins to treat cystic fibrosis and chronic pancreatitis. He successfully brought drug candidates\u00a0from preclinical to clinical phases\u00a0and handled the preparation of\u00a0regulatory documents\u00a0to support Phase 2 CTA. Mathieu leads projects to define\u00a0innovative development plan strategies\u00a0of drug candidates specifically for ear disorders as well as identifying\u00a0reference compounds in the various indications of hearing\u00a0for Cilcare\u2019s clients.","og_url":"https:\/\/www.cilcare.com\/jp\/team\/mathieu-schue-ph-d\/","og_site_name":"Cilcare","article_modified_time":"2025-05-16T12:53:47+00:00","og_image":[{"width":610,"height":763,"url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Mathieu.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/","url":"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/","name":"Mathieu SCHUE, Ph.D - Cilcare","isPartOf":{"@id":"https:\/\/www.cilcare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/#primaryimage"},"image":{"@id":"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Mathieu.jpg","datePublished":"2024-12-12T14:17:36+00:00","dateModified":"2025-05-16T12:53:47+00:00","breadcrumb":{"@id":"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/#primaryimage","url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Mathieu.jpg","contentUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Mathieu.jpg","width":610,"height":763},{"@type":"BreadcrumbList","@id":"https:\/\/www.cilcare.com\/team\/mathieu-schue-ph-d\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cilcare.com\/"},{"@type":"ListItem","position":2,"name":"Mathieu SCHUE, Ph.D"}]},{"@type":"WebSite","@id":"https:\/\/www.cilcare.com\/#website","url":"https:\/\/www.cilcare.com\/","name":"Cilcare","description":"Making hearing a priority","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cilcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"}]}},"_links":{"self":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/team\/12790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/team"}],"about":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/types\/team"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media\/9612"}],"wp:attachment":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media?parent=12790"}],"wp:term":[{"taxonomy":"category-team","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/category-team?post=12790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}